Home

Articles from Neurogen Biomarking

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians
Neurogen’s Brain Health Care Ecosystem Accelerates Access to Early Detection Technology for Alzheimer’s dementia and Mild Cognitive Impairment
By Neurogen Biomarking · Via GlobeNewswire · May 1, 2025
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer’s Disease
Neurogen Biomarking’s Brain Health Care Ecosystem Gives Patients Easier Access to Clinically Validated Blood Biomarker Technology
By Neurogen Biomarking · Via GlobeNewswire · February 19, 2025
Neurogen Biomarking Announces Collaboration with Linus Health Bringing Easy Access to Cutting-Edge Technology to Support Early Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease
Neurogen Biomarking, the world’s first ecosystem for memory loss with end-to-end patient support and Linus Health, a digital health company focused on transforming brain health for people worldwide, finalized an agreement to integrate Linus Health's scientifically-validated digital cognitive assessments into the Neurogen Biomarking ecosystem.
By Neurogen Biomarking · Via Business Wire · January 14, 2025